PMID- 37530803 OWN - NLM STAT- MEDLINE DCOM- 20230824 LR - 20230928 IS - 1432-1750 (Electronic) IS - 0341-2040 (Linking) VI - 201 IP - 4 DP - 2023 Aug TI - Genetic Association of Circulating Adipokines with Risk of Idiopathic Pulmonary Fibrosis: A Two-Sample Mendelian Randomization Study. PG - 355-362 LID - 10.1007/s00408-023-00640-8 [doi] AB - PURPOSE: The causal relationships between circulating adipokines and idiopathic pulmonary fibrosis (IPF) are yet to be established. We performed a two-sample Mendelian randomization (MR) study to investigate the causal roles of adipokines on IPF risk. METHODS: We analyzed the summary data from genome-wide association studies (GWAS), including adiponectin, leptin, resistin and monocyte chemoattractant protein-1 (MCP-1) and IPF. The inverse-variance weighted (IVW) method was considered as the major method and the MR-Egger, weighted median, simple mode and weighted mode were utilized as complementary methods. We also performed the sensitivity analyses, including heterogeneity test, horizontal pleiotropy test and leave-one-out analysis. RESULTS: The selected number of single nucleotide polymorphisms (SNPs) was 13 for adiponectin, 6 for leptin,12 for resistin, and 6 for MCP-1, respectively. The results showed a causal effect of the circulating adiponectin levels on the risk of IPF (OR 0.645, 95% CI 0.457-0.911, P = 0.013). However, we did not observe significant associations of genetic changes in serum leptin (OR 1.018, 95% CI 0.442-2.346, P = 0.967), resistin (OR 1.002, 95% CI 0.712-1.408, P = 0.993), and MCP-1 (OR 1.358, 95% CI 0.891-2.068, P = 0.155) with risk of developing IPF. There was no evidence of heterogeneity or horizontal pleiotropy. The sensitivity analyses confirmed that our results were stable and reliable. CONCLUSIONS: The increase in serum adiponectin was associated causally with a decreased risk of developing IPF. There is no evidence to support a causal association between leptin, resistin or MCP-1 with risk of IPF. Further studies are needed to confirm our findings. CI - (c) 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. FAU - Huang, Dong AU - Huang D AD - Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu, 610041, Sichuan, China. AD - Institute of Clinical Pathology, Key Laboratory of Transplant Engineering and Immunology, NHC, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu, 610041, Sichuan, China. FAU - Gong, Linjing AU - Gong L AD - Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu, 610041, Sichuan, China. AD - Institute of Clinical Pathology, Key Laboratory of Transplant Engineering and Immunology, NHC, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu, 610041, Sichuan, China. FAU - Wu, Zhenru AU - Wu Z AD - Institute of Clinical Pathology, Key Laboratory of Transplant Engineering and Immunology, NHC, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu, 610041, Sichuan, China. FAU - Shi, Yujun AU - Shi Y AD - Institute of Clinical Pathology, Key Laboratory of Transplant Engineering and Immunology, NHC, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu, 610041, Sichuan, China. shiyujun@scu.edu.cn. FAU - Liang, Zongan AU - Liang Z AD - Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu, 610041, Sichuan, China. liangza@scu.edu.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20230802 PL - United States TA - Lung JT - Lung JID - 7701875 RN - 0 (Adipokines) RN - 0 (Resistin) RN - 0 (Leptin) RN - 0 (Adiponectin) SB - IM MH - Humans MH - *Adipokines MH - Resistin/genetics MH - Leptin/genetics MH - Adiponectin/genetics MH - Genome-Wide Association Study MH - Mendelian Randomization Analysis MH - *Idiopathic Pulmonary Fibrosis/genetics MH - Polymorphism, Single Nucleotide OTO - NOTNLM OT - Adipokines OT - Adiponectin OT - Idiopathic pulmonary fibrosis OT - Mendelian randomization EDAT- 2023/08/02 13:08 MHDA- 2023/08/24 06:42 CRDT- 2023/08/02 11:04 PHST- 2023/05/23 00:00 [received] PHST- 2023/07/25 00:00 [accepted] PHST- 2023/08/24 06:42 [medline] PHST- 2023/08/02 13:08 [pubmed] PHST- 2023/08/02 11:04 [entrez] AID - 10.1007/s00408-023-00640-8 [pii] AID - 10.1007/s00408-023-00640-8 [doi] PST - ppublish SO - Lung. 2023 Aug;201(4):355-362. doi: 10.1007/s00408-023-00640-8. Epub 2023 Aug 2.